Gene · 7003
Papers2,415
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 2,415
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating Long Non-Coding RNAs LINC00324 and LOC100507053 as Potential Liquid Biopsy Markers for Esophageal Squamous Cell Carcinoma: A Pilot Study. | Front Oncol | 2022 | 35237522 | PubTator, text mining | PubMed |
| Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer. | Nat Commun | 2022 | 35217640 | PubTator, text mining | PubMed |
| Identification, Culture and Targeting of Cancer Stem Cells. | Life (Basel) | 2022 | 35207472 | PubTator, text mining | PubMed |
| Assays Used for Discovering Small Molecule Inhibitors of YAP Activity in Cancers. | Cancers (Basel) | 2022 | 35205777 | PubTator, text mining | PubMed |
| Identification of phenotype-specific networks from paired gene expression-cell shape imaging data. | Genome Res | 2022 | 35197309 | PubTator, text mining | PubMed |
| Increased Expression of YAP Inhibited the Autophagy Level by Upregulating mTOR Signal in the Eutopic ESCs of Endometriosis. | Front Endocrinol (Lausanne) | 2022 | 35173685 | PubTator, text mining | PubMed |
| MiR-597-5p suppresses the progression of hepatocellular carcinoma via targeting transcriptional enhancer associate domain transcription factor 1 (TEAD1). | In Vitro Cell Dev Biol Anim | 2022 | 35169903 | PubTator, text mining | PubMed |
| Revisiting miRNA Association with Melanoma Recurrence and Metastasis from a Machine Learning Point of View. | Int J Mol Sci | 2022 | 35163222 | PubTator, text mining | PubMed |
| Thyridium revised: Synonymisation of Phialemoniopsis under Thyridium and establishment of a new order, Thyridiales. | MycoKeys | 2022 | 35145340 | PubTator, text mining | PubMed |
| 14-3-3 Proteins are Potential Regulators of Liquid-Liquid Phase Separation. | Cell Biochem Biophys | 2022 | 35142991 | PubTator, text mining | PubMed |
| Dimethyl Fumarate Combined With Vemurafenib Enhances Anti-Melanoma Efficacy via Inhibiting the Hippo/YAP, NRF2-ARE, and AKT/mTOR/ERK Pathways in A375 Melanoma Cells. | Front Oncol | 2022 | 35141161 | PubTator, text mining | PubMed |
| Human transcription factor protein interaction networks. | Nat Commun | 2022 | 35140242 | PubTator, text mining | PubMed |
| YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overload. | J Clin Invest | 2022 | 35133975 | PubTator, text mining | PubMed |
| Emerging roles of inflammation-mediated endothelial-mesenchymal transition in health and disease. | Inflamm Regen | 2022 | 35130955 | PubTator, text mining | PubMed |
| ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation. | Nat Commun | 2022 | 35121738 | PubTator, text mining | PubMed |
| Protein kinases in cardiovascular diseases. | Chin Med J (Engl) | 2022 | 35120357 | PubTator, text mining | PubMed |
| Novel insights from a multiomics dissection of the Hayflick limit. | Elife | 2022 | 35119359 | PubTator, text mining | PubMed |
| Alterations in chromatin accessibility during osteoblast and adipocyte differentiation in human mesenchymal stem cells. | BMC Med Genomics | 2022 | 35101056 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction by TFAM depletion disrupts self-renewal and lineage differentiation of human PSCs by affecting cell proliferation and YAP response. | Redox Biol | 2022 | 35091324 | PubTator, text mining | PubMed |
| CircPVT1: a pivotal circular node intersecting Long Non-Coding-PVT1 and c-MYC oncogenic signals. | Mol Cancer | 2022 | 35090471 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7003/papers?page=45